Revenue: The sum of all revenue fields included for a company's operating activities.
Blueprint Medicines Corporation (BPMC) had Revenue of $508.82M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$508.82M |
$-67.09M |
|
$20.16M |
|
$488.66M |
|
$720.87M |
|
$-212.04M |
|
$146.18M |
|
$-65.86M |
|
$-65.86M |
|
$-67.09M |
|
$-67.09M |
|
$-67.09M |
|
$-67.09M |
|
$-212.04M |
|
$-218.22M |
|
62.86M |
|
62.86M |
|
$-1.07 |
|
$-1.07 |
|
| Balance Sheet Financials | |
$742.68M |
|
$36.59M |
|
$437.13M |
|
$1.18B |
|
$260.80M |
|
$343.05M |
|
$620.35M |
|
$881.15M |
|
$298.67M |
|
$298.67M |
|
$298.67M |
|
63.71M |
|
| Cash Flow Statement Financials | |
$-192.59M |
|
$-47.50M |
|
$273.11M |
|
$81.52M |
|
$113.64M |
|
$32.12M |
|
$108.91M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.85 |
|
-- |
|
-- |
|
0.53 |
|
1.30 |
|
96.04% |
|
-41.67% |
|
-41.67% |
|
-42.89% |
|
-12.94% |
|
-13.19% |
|
$-197.22M |
|
-- |
|
-- |
|
-- |
|
0.43 |
|
1.48 |
|
6.56 |
|
55.67 |
|
-22.46% |
|
-22.46% |
|
-5.69% |
|
-10.45% |
|
$4.69 |
|
$-3.14 |
|
$-3.06 |
|